Moderate riskFDA DrugClass II

Shoolin Pharma Chem sildenafil citrate recalled for CGMP manufacturing deviations

The FDA identified Current Good Manufacturing Practice (CGMP) deviations during an inspection of Shoolin Pharma Chem LLP's facility in India. Sildenafil citrate bulk powder (batch SDC2505001, expiring April 30, 2030) distributed nationwide for prescription compounding did not meet required manufacturing standards.

From the FDA notice · Read the official notice ↗

What to do

  1. If you are a pharmacy or compounding facility, do not use sildenafil citrate from batch SDC2505001.
  2. Contact your supplier or the FDA for guidance on affected inventory.
  3. Consult the FDA's full recall notice for specific lot numbers and distribution details.

Is yours affected?

Compare your label or packaging with the recalled product.

Product
SILDENAFIL CITRATE USP, 0.100 KG, 100 gm-bag Net Wt, RX ONLY "FOR Prescription Compounding Only", Shoolin Pharma Chem LLP, Block/Survey no 408, B/H Ratnamani Tubes, Near Maruti Inox, Indrad, Kadi, Mahesana, Gujarat, 382715, India, (CAS NO. 171599-83-0) NDC 85702-001-05
Sold in
Nationwide
Made for
All ages (0 months and older)

This recall covers 5 products — see all of them.

Details

Units affected
25KG, 250-1gm bags
Illnesses reported
None reported
Manufactured in
408 B/H Ratnamani Tubes, Block/Survey No; Nr Maruti Inox, Kadi, India
Classification
Class II
Recall number
D-0759-2026

In the FDA's words

Description
SILDENAFIL CITRATE USP, 0.100 KG, 100 gm-bag Net Wt, RX ONLY "FOR Prescription Compounding Only", Shoolin Pharma Chem LLP, Block/Survey no 408, B/H Ratnamani Tubes, Near Maruti Inox, Indrad, Kadi, Mahesana, Gujarat, 382715, India, (CAS NO. 171599-83-0) NDC 85702-001-05 CGMP Deviations:Noted during FDA inspection Batch SDC2505001, Date of Expiry: April 30, 2030. Distribution: Distributed Nationwide in the USA Affected quantity: 25KG, 250-1gm bags
Hazard
CGMP Deviations:Noted during FDA inspection

5 products in this recall

Shoolin Pharma sildenafil and tadalafil powders recalled for manufacturing violations

Shoolin Pharma Chem LLP is recalling five bulk powder products, sildenafil citrate and tadalafil in 100-gram, 500-gram, and 1-kilogram sizes, sold for prescription compounding only. The recall was triggered by manufacturing practice (CGMP) deviations found during an FDA inspection, and no injuries have been reported. The products were distributed nationwide.

The agency lists each product separately. Check every one you might have.

Related topics

OtherDrugsSold nationwideMore from FDA Drug